Shisi Pharmaceutical Group (02005) obtained drug production registration approval for vitamin K1 injection (1ml: 10mg)

Zhitong Finance App News, Shisi Pharmaceutical Group (02005) issued an announcement. The group has obtained the drug production registration approval for vitamin K1 injection (1ml: 10mg) from the China National Drug Administration. It is a Class 3 chemical drug, which is deemed to have passed the consistency evaluation.

Vitamin K1 injections are mainly used to treat bleeding due to vitamin K deficiency and prevent vitamin K deficiency that cannot be obtained through nutritional supplementation. Vitamin K1 injection is a basic clinical drug. It is widely used for bleeding prevention and first aid, and the market is huge. The approval of this product has enriched the Group's injectable product portfolio.